BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8293471)

  • 1. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.
    Kemble GW; Danieli T; White JM
    Cell; 1994 Jan; 76(2):383-91. PubMed ID: 8293471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes.
    Melikyan GB; White JM; Cohen FS
    J Cell Biol; 1995 Nov; 131(3):679-91. PubMed ID: 7593189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin.
    Nüssler F; Clague MJ; Herrmann A
    Biophys J; 1997 Nov; 73(5):2280-91. PubMed ID: 9370425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity.
    Kemble GW; Henis YI; White JM
    J Cell Biol; 1993 Sep; 122(6):1253-65. PubMed ID: 8397215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion.
    Melikyan GB; Brener SA; Ok DC; Cohen FS
    J Cell Biol; 1997 Mar; 136(5):995-1005. PubMed ID: 9060465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
    Markosyan RM; Cohen FS; Melikyan GB
    Mol Biol Cell; 2000 Apr; 11(4):1143-52. PubMed ID: 10749920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple local contact sites are induced by GPI-linked influenza hemagglutinin during hemifusion and flickering pore formation.
    Frolov VA; Cho MS; Bronk P; Reese TS; Zimmerberg J
    Traffic; 2000 Aug; 1(8):622-30. PubMed ID: 11208150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.
    Armstrong RT; Kushnir AS; White JM
    J Cell Biol; 2000 Oct; 151(2):425-37. PubMed ID: 11038188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural intermediates in influenza haemagglutinin-mediated fusion.
    Chernomordik LV; Leikina E; Kozlov MM; Frolov VA; Zimmerberg J
    Mol Membr Biol; 1999; 16(1):33-42. PubMed ID: 10332735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetically differentiating influenza hemagglutinin fusion and hemifusion machines.
    Mittal A; Leikina E; Chernomordik LV; Bentz J
    Biophys J; 2003 Sep; 85(3):1713-24. PubMed ID: 12944286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary structure, orientation, oligomerization, and lipid interactions of the transmembrane domain of influenza hemagglutinin.
    Tatulian SA; Tamm LK
    Biochemistry; 2000 Jan; 39(3):496-507. PubMed ID: 10642174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.
    Takeda M; Leser GP; Russell CJ; Lamb RA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14610-7. PubMed ID: 14561897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
    Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
    J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of X31 influenza virus fusion on phosphatidylserine asymmetry in erythrocytes.
    Pak CC; Blumenthal R
    Biochim Biophys Acta; 1996 Jan; 1278(1):98-104. PubMed ID: 8611613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.
    Chernomordik LV; Frolov VA; Leikina E; Bronk P; Zimmerberg J
    J Cell Biol; 1998 Mar; 140(6):1369-82. PubMed ID: 9508770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane fusion. Anchors aweigh.
    Stegmann T
    Curr Biol; 1994 Jun; 4(6):551-4. PubMed ID: 7922379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Hemifusion Phenotype Depends on Membrane Context: Differences in Cell-Cell and Virus-Cell Fusion.
    Zawada KE; Okamoto K; Kasson PM
    J Mol Biol; 2018 Mar; 430(5):594-601. PubMed ID: 29355500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Configuration of influenza hemagglutinin fusion peptide monomers and oligomers in membranes.
    Sammalkorpi M; Lazaridis T
    Biochim Biophys Acta; 2007 Jan; 1768(1):30-8. PubMed ID: 16999933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge.
    Razinkov VI; Melikyan GB; Cohen FS
    Biophys J; 1999 Dec; 77(6):3144-51. PubMed ID: 10585935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.